These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 35233728

  • 1. Population Pharmacokinetics of Flucloxacillin In Bone and Soft Tissue- Standard Dosing is Not Sufficient to Achieve Therapeutic Concentrations.
    Öbrink-Hansen K, Pham AD, Bue M, Hanberg P, Bendtsen M, Slater J, Friberg LE, Thorsted A, Stilling M.
    Pharm Res; 2022 Jul; 39(7):1633-1643. PubMed ID: 35233728
    [Abstract] [Full Text] [Related]

  • 2. Steady-state concentrations of flucloxacillin in porcine vertebral cancellous bone and intervertebral disc following oral and intravenous administration assessed by microdialysis.
    Bendtsen MAF, Hanberg P, Slater J, Hansen J, Öbrink-Hansen K, Stilling M, Bue M.
    Eur Spine J; 2022 Jun; 31(6):1508-1514. PubMed ID: 35488132
    [Abstract] [Full Text] [Related]

  • 3. Flucloxacillin bone and soft tissue concentrations assessed by microdialysis in pigs after intravenous and oral administration.
    Bendtsen MAF, Bue M, Hanberg P, Slater J, Thomassen MB, Hansen J, Søballe K, Öbrink-Hansen K, Stilling M.
    Bone Joint Res; 2021 Jan; 10(1):60-67. PubMed ID: 33448872
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Population Pharmacokinetics of Meropenem in Plasma and Subcutis from Patients on Extracorporeal Membrane Oxygenation Treatment.
    Hanberg P, Öbrink-Hansen K, Thorsted A, Bue M, Tøttrup M, Friberg LE, Hardlei TF, Søballe K, Gjedsted J.
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530848
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Optimization of β-Lactam Dosing Regimens in Neonatal Infections: Continuous and Extended Administration versus Intermittent Administration.
    Leegwater E, Wewerinke L, de Grauw AM, van Veen M, Storm BN, Kruizinga MD.
    Clin Pharmacokinet; 2023 May; 62(5):715-724. PubMed ID: 36972008
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Population pharmacokinetic modelling of total and unbound flucloxacillin in non-critically ill patients to devise a rational continuous dosing regimen.
    Wilkes S, van Berlo I, Ten Oever J, Jansman F, Ter Heine R.
    Int J Antimicrob Agents; 2019 Mar; 53(3):310-317. PubMed ID: 30472288
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Population pharmacokinetics of free flucloxacillin in patients treated with oral flucloxacillin plus probenecid.
    Drennan PG, Green JK, Gardiner SJ, Metcalf SCL, Kirkpatrick CMJ, Everts RJ, Zhang M, Chambers ST.
    Br J Clin Pharmacol; 2021 Dec; 87(12):4681-4690. PubMed ID: 33963595
    [Abstract] [Full Text] [Related]

  • 14. Optimization of flucloxacillin dosing regimens in critically ill patients using population pharmacokinetic modelling of total and unbound concentrations.
    Jager NGL, van Hest RM, Xie J, Wong G, Ulldemolins M, Brüggemann RJM, Lipman J, Roberts JA.
    J Antimicrob Chemother; 2020 Sep 01; 75(9):2641-2649. PubMed ID: 32443147
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A Population Pharmacokinetic Analysis of Continuous Infusion of Cloxacillin during Staphylococcus aureus Bone and Joint Infections.
    Courjon J, Garzaro M, Roger PM, Ruimy R, Lavrut T, Chelli M, Raynier JL, Chirio D, Demonchy E, Cabane L, Jehl F, Trojani C, Grillon A, Goutelle S.
    Antimicrob Agents Chemother; 2020 Nov 17; 64(12):. PubMed ID: 32988822
    [Abstract] [Full Text] [Related]

  • 17. The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis.
    Leder K, Turnidge JD, Korman TM, Grayson ML.
    J Antimicrob Chemother; 1999 Jan 17; 43(1):113-8. PubMed ID: 10381108
    [Abstract] [Full Text] [Related]

  • 18. Frequency of pharmacological target attainment with flucloxacillin and cefazolin in invasive methicillin-susceptible Staphylococcus aureus infection: a prospective cohort study in hospitalized patients.
    Campbell PO, Chin PKL, Dalton SC, Metcalf SCL, Douglas NM, Chambers ST.
    Int J Antimicrob Agents; 2023 Jan 17; 61(1):106695. PubMed ID: 36464153
    [Abstract] [Full Text] [Related]

  • 19. Intermittent Short-Term Infusion vs. Continuous Infusion of Piperacillin: Steady State Concentrations in Porcine Cervical Spine Tissue Evaluated by Microdialysis.
    Petersen EK, Hanberg P, Knudsen M, Tøstesen SK, Jørgensen AR, Öbrink-Hansen K, Søballe K, Stilling M, Bue M.
    Antibiotics (Basel); 2022 Jul 07; 11(7):. PubMed ID: 35884164
    [Abstract] [Full Text] [Related]

  • 20. Bone, subcutaneous tissue and plasma pharmacokinetics of cefuroxime in total knee replacement patients - a randomized controlled trial comparing continuous and short-term infusion.
    Tøttrup M, Søballe K, Bibby BM, Hardlei TF, Hansen P, Fuursted K, Birke-Sørensen H, Bue M.
    APMIS; 2019 Dec 07; 127(12):779-788. PubMed ID: 31515843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.